Clarithromycin as an immunomodulator in sepsis: still a (IN)CLASS act

Detalles Bibliográficos
Autores principales: Snow, Timothy Arthur Chandos, Cesar, Antonio, Singer, Mervyn, Arulkumaran, Nishkantha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354275/
https://www.ncbi.nlm.nih.gov/pubmed/35932059
http://dx.doi.org/10.1186/s13054-022-04104-y
_version_ 1784763031548329984
author Snow, Timothy Arthur Chandos
Cesar, Antonio
Singer, Mervyn
Arulkumaran, Nishkantha
author_facet Snow, Timothy Arthur Chandos
Cesar, Antonio
Singer, Mervyn
Arulkumaran, Nishkantha
author_sort Snow, Timothy Arthur Chandos
collection PubMed
description
format Online
Article
Text
id pubmed-9354275
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93542752022-08-06 Clarithromycin as an immunomodulator in sepsis: still a (IN)CLASS act Snow, Timothy Arthur Chandos Cesar, Antonio Singer, Mervyn Arulkumaran, Nishkantha Crit Care Correspondence BioMed Central 2022-08-05 /pmc/articles/PMC9354275/ /pubmed/35932059 http://dx.doi.org/10.1186/s13054-022-04104-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correspondence
Snow, Timothy Arthur Chandos
Cesar, Antonio
Singer, Mervyn
Arulkumaran, Nishkantha
Clarithromycin as an immunomodulator in sepsis: still a (IN)CLASS act
title Clarithromycin as an immunomodulator in sepsis: still a (IN)CLASS act
title_full Clarithromycin as an immunomodulator in sepsis: still a (IN)CLASS act
title_fullStr Clarithromycin as an immunomodulator in sepsis: still a (IN)CLASS act
title_full_unstemmed Clarithromycin as an immunomodulator in sepsis: still a (IN)CLASS act
title_short Clarithromycin as an immunomodulator in sepsis: still a (IN)CLASS act
title_sort clarithromycin as an immunomodulator in sepsis: still a (in)class act
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354275/
https://www.ncbi.nlm.nih.gov/pubmed/35932059
http://dx.doi.org/10.1186/s13054-022-04104-y
work_keys_str_mv AT snowtimothyarthurchandos clarithromycinasanimmunomodulatorinsepsisstillainclassact
AT cesarantonio clarithromycinasanimmunomodulatorinsepsisstillainclassact
AT singermervyn clarithromycinasanimmunomodulatorinsepsisstillainclassact
AT arulkumarannishkantha clarithromycinasanimmunomodulatorinsepsisstillainclassact

Ejemplares similares